Celiac Disease Antibody Screen
Celiac Disease Antibody Screen | | | |
| Number | | 334971 |
| CPT | | 82784; 83516 (x2) |
| Synonyms | | Celiac ; Gliadin ; Deamidated Gliadin Antibodies (DGP) ;
tissue transglutaminase (tTG) Antibodies |
| Test Includes | | Deamidated gliadin IgA; tissue transglutaminase IgA; and
serum IgA quantitation |
| Specimen | | Serum |
| Volume | | 3 mL |
| Minimum Volume | | 1 mL |
| Container | | Red-top tube or gel-barrier tube |
| Collection | | To avoid delays in turnaround time when requesting multiple
tests on frozen samples, please submit separate frozen
specimens for each test requested. |
| Storage Instructions | | Ship at room temperature, store refrigerated for up to 48
hours and then freeze at -20°C for longer storage |
| Causes for Rejection | | Hemolysis; lipemia; gross bacterial contamination |
| Use | | Aid in the diagnosis of gluten-sensitive enteropathies. |
| Methodology | | Enzyme immunoassay (EIA); indirect immunofluorescence |
| Additional Information | | Celiac disease is a gluten enteropathy occurring in both
children and adults. The disease is probably
underdiagnosed in that it may affect as much as 1% of the
population in the United States. The condition is
characterized by a sensitivity to gluten (found in wheat,
barley, and rye) that causes inflammation and atrophy of
the villi of the small intestine, malabsorption, etc. This
sensitivity to gluten may also be seen in dermatitis
herpetiformis. Strict avoidance of gluten in the diet will
control disease activity, and antibodies to serum markers
will disappear with time. |
| References | | NIH Consensus and State-of-the-Science
Statement on Celiac Disease. NIH Consens State Sci
Statements. 2004; 21:1-22.
Agardh D. Antibodies against synthetic deamidated
gliadin peptides and tissue transglutaminase for the
identification of childhood celiac disease. Clin
Gastroenterol Hepatol. 2007 Nov; 5(11):1276-1281.
Green PH, Cellier C. Celiac disease. N Engl J
Med. 2007 Oct 25; 357(17):1731-1743.
Hill ID, Dirks MH, Liptak GS, et al. Guideline for the
diagnosis and treatment of celiac disease in children:
Recommendations of the North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition. J Pediatr
Gastroenterol Nutr. 2005 Jan; 40(1):1-19.
Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen
J, Mäki M. Resurrection of gliadin antibodies in coeliac
disease. Deamidated gliadin peptide antibody test provides
additional diagnostic benefit. Scand J
Gastroenterol. 2007 Dec; 42(12):1428-1433.
Mothes T. Deamidated gliadin peptides as targets for
celiac disease-specific antibodies. Adv Clin Chem.
2007; 44:35-63.
Rashtak S, Ettore MW, Homburger HA, Murray JA.
Comparative usefulness of deamidated gliadin antibodies in
the diagnosis of celiac disease. Clin Gastroenterol
Hepatol. 2008 Apr; 6(4):426-432; quiz 370.
Schwertz E, Kahlenberg F, Sack U, et al. Serologic
assay based on gliadin-related nonapeptides as a highly
sensitive and specific diagnostic aid in celiac disease.
Clin Chem. 2004 Dec; 50(12):2370-2375.
Sugai E, Vázguez H, Nachman F, et al. Accuracy of
testing for antibodies to synthetic gliadin-related
peptides in celiac disease. Clin Gastroenterol
Hepatol. 2006 Sep; 4(9):1112-1117. |
|